News

MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
The new weight loss drug which is set to give Ozempic and Mounjaro a run for their money, MariTide, is taken on a monthly basis rather than weekly.
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...
In the same way weight varies from person to person, so do the best weight loss strategies. While some people succeed with diet and exercise alone, others find that adding weight loss medications like ...
At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP ...
The once-monthly drug is still under study but could provide added convenience and another option for patients.
Drugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same ...
MariTide is designed to combine the effects of glucagon-like peptide-1 (GLP-1) receptor activation with glucose-dependent ...
Amgen's weight-loss drug MariTide had a successful Phase 2 trial so the company is expanding development plans to study its use for heart disease and sleep apnea.